GALA Dallas Conference 2018

GALA Dallas Conference – 2018

Click link for access to slides.

WELCOME/INTRODUCTION• Conference Chairs: Mack Mitchell, MD, and Lawrence Schiller, MD

EVALUATION OF CHRONIC DIARRHEA AND IBS-D IN THE ERA OF PRECISION MEDICINE• Lawrence Schiller, MD

CHRONIC IDIOPATHIC CONSTIPATION AND OPIOID-INDUCED CONSTIPATION: THE SAME BUT DIFFERENT..• William Chey, MD

GUT MICROBIOTA AND GASTROINTESTINAL HEALTH: THE BASICS AND WHAT’S NEW• Christopher Chang, MD

AN UPDATE ON THE PHARMACOLOGIC TREATMENT OF NAFLD/NASH: BEYOND LIFESTYLE MODIFICATIONS• Naim Alkhouri, MD

AUTOIMMUNE BILIARY DISEASE: DIAGNOSIS AND MANAGEMENT OF PBC AND PSC• John Vierling, MD

ALCOHOL-RELATED HEPATITIS• Mack Mitchell, MD

CURRENT DILEMMAS IN CHRONIC HEPATITIS C MANAGEMENT

CASE 1: HOW TO CHOOSE YOUR HCV THERAPY: A NUC OR PI BASED REGIMEN• Robert Brown, MD

CASE 2: DEALING WITH HBV COINFECTION, RISK OF HCC AFTER SVR AND TREATING PATIENTS WITH CIRRHOSIS AND RENAL IMPAIRMENT• Paul Kwo, MD

CURRENT DILEMMAS IN DIAGNOSING LIVER MASSES

CASE 1: DIAGNOSIS AND MANAGEMENT OF BENIGN LIVER TUMORS: HOW TO DISTINGUISH LESIONS WITH IMAGING AND WHEN A BIOPSY IS NEEDED• Kimberly Brown, MD

CASE 2: DIAGNOSIS AND MANAGEMENT OF HCC: RESECT, ABLATE OR TRANSPLANT? WHEN IS A BIOPSY NEEDED AND WHEN IS AN ONCOLOGIST NEEDED?• Laura Kulik, MD

THE EVOLVING ROLE OF THERAPEUTIC DRUG MONITORING IN IBD• Gary Lichtenstein, MD

UPDATE ON IMMUNOMODULATORS IN IBD• Themistocles Dassopoulos, MD

THE DIAGNOSIS AND MANAGEMENT OF HEREDITARY COLORECTAL CANCER SYNDROMES• C. Richard Boland, MD

PROTON PUMP INHIBITORS: HOW AND WHEN TO USE IN THE CURRENT ENVIRONMENT• Stuart Spechler, MD

REFRACTORY HEARTBURN: ALL ROADS LEAD TO ROME• Ronnie Fass, MD

ACHALASIA: CURRENT DIAGNOSTIC WORKUP AND MANAGEMENT• Vani Konda, MD

Author Info

Sean Hendrickson